Eligard (leuprorelin acetate) powder and solvent for prolonged-release injection — original (Astellas, Netherlands) Indications Treatment of hormone-dependent advanced prostate cancer and treatment of high-risk localized prostate cancer and locally advanced prostate cancer in combination with radiation therapy
Indications
Treatment of hormone-dependent advanced prostate cancer and treatment of high-risk localized and locally advanced prostate cancer in combination with radiation.
- Trade Name:Eligard
- Chemical Name:Leuprorelin
- Dosage:22.5 mg
- Form of Issue:Ampoule
No reviews yet